Department of Life Sciences and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Megeno S.A., Esch-sur-Alzette, Luxembourg.
NPJ Syst Biol Appl. 2021 Jan 22;7(1):5. doi: 10.1038/s41540-020-00159-1.
Metabolic modeling enables the study of human metabolism in healthy and in diseased conditions, e.g., the prediction of new drug targets and biomarkers for metabolic diseases. To accurately describe blood and urine metabolite dynamics, the integration of multiple metabolically active tissues is necessary. We developed a dynamic multi-tissue model, which recapitulates key properties of human metabolism at the molecular and physiological level based on the integration of transcriptomics data. It enables the simulation of the dynamics of intra-cellular and extra-cellular metabolites at the genome scale. The predictive capacity of the model is shown through the accurate simulation of different healthy conditions (i.e., during fasting, while consuming meals or during exercise), and the prediction of biomarkers for a set of Inborn Errors of Metabolism with a precision of 83%. This novel approach is useful to prioritize new biomarkers for many metabolic diseases, as well as for the integration of various types of personal omics data, towards the personalized analysis of blood and urine metabolites.
代谢建模能够研究健康和疾病状态下的人体代谢,例如,预测新的药物靶点和代谢疾病的生物标志物。为了准确描述血液和尿液代谢物的动态变化,需要整合多个代谢活跃的组织。我们开发了一种动态的多组织模型,该模型基于转录组学数据的整合,在分子和生理水平上再现了人体代谢的关键特性。它能够模拟细胞内和细胞外代谢物在基因组尺度上的动态变化。该模型的预测能力通过对不同健康状态(如禁食、进食或运动期间)的准确模拟以及对一组遗传代谢缺陷的生物标志物的预测(精度为 83%)得到了验证。这种新方法有助于为许多代谢疾病确定新的生物标志物的优先级,也有助于整合各种类型的个人组学数据,从而实现对血液和尿液代谢物的个性化分析。